In the phase 3 study, the investigational monoclonal antibody, VYD2311, had fewer adverse events than an mRNA #COVID19 vaccine, and it did not blunt vaccine-induced neutralizing titers when the 2 were given together. @invivyd.bsky.social #IDsky #Medsky
www.contagionlive.com/view/vyd2311...
www.contagionlive.com/view/vyd2311...
September 29, 2026 at 3:28 PM
In the phase 3 study, the investigational monoclonal antibody, VYD2311, had fewer adverse events than an mRNA #COVID19 vaccine, and it did not blunt vaccine-induced neutralizing titers when the 2 were given together. @invivyd.bsky.social #IDsky #Medsky
www.contagionlive.com/view/vyd2311...
www.contagionlive.com/view/vyd2311...
Our comment published this month in @lancetmicrobe.bsky.social
Differential success of human papillomavirus vaccination in people living with HIV and solid organ transplant recipients: lessons for vaccine design in immunocompromised individuals.
#IDSky #HPV
www.thelancet.com/journals/lan...
Differential success of human papillomavirus vaccination in people living with HIV and solid organ transplant recipients: lessons for vaccine design in immunocompromised individuals.
#IDSky #HPV
www.thelancet.com/journals/lan...
Differential success of human papillomavirus vaccination in people living with HIV and solid organ transplant recipients: lessons for vaccine design in immunocompromised individuals
We read with great interest the Article by John T Schiller and colleagues1 published
in The Lancet Microbe; this Article reported the factors contributing to the potency
of human papillomavirus (HPV) ...
www.thelancet.com
September 29, 2026 at 2:51 PM
Our comment published this month in @lancetmicrobe.bsky.social
Differential success of human papillomavirus vaccination in people living with HIV and solid organ transplant recipients: lessons for vaccine design in immunocompromised individuals.
#IDSky #HPV
www.thelancet.com/journals/lan...
Differential success of human papillomavirus vaccination in people living with HIV and solid organ transplant recipients: lessons for vaccine design in immunocompromised individuals.
#IDSky #HPV
www.thelancet.com/journals/lan...
September 29, 2026 at 2:21 PM
The monoclonal antibody, Brelovitug, met the combined virologic and ALT response end point at week 24 in AZURE-1, with 56% response on 300 mg weekly and 45% on 900 mg every four weeks. #hepatitis #IDsky
www.contagionlive.com/view/monoclo...
www.contagionlive.com/view/monoclo...
Monoclonal Antibody Meets Primary End Point in Phase 3 Hepatitis D Trial | Contagion Live
The monoclonal antibody, Brelovitug, met the combined virologic and ALT response end point at week 24 in AZURE-1, with 56% response on 300 mg weekly and 45% on 900 mg every four weeks. The manufacture...
www.contagionlive.com
September 29, 2026 at 2:00 PM
The monoclonal antibody, Brelovitug, met the combined virologic and ALT response end point at week 24 in AZURE-1, with 56% response on 300 mg weekly and 45% on 900 mg every four weeks. #hepatitis #IDsky
www.contagionlive.com/view/monoclo...
www.contagionlive.com/view/monoclo...
💊Manikomycin, the new antibiokid on the block!🧫
#MicrobioSky #IDSky #MedSky #AMR #AntimicrobialResistance
#MicrobioSky #IDSky #MedSky #AMR #AntimicrobialResistance
GOOD NEWS! Researchers have discovered a new antibiotic, known as manikomycin, that may be a bulwark in the fight against drug-resistant superbugs. By attacking the ribosome in a never-before-seen way, manikomycin can evade the existing mechanisms pathogens have developed to resist antibiotics.
September 29, 2026 at 1:06 PM
💊Manikomycin, the new antibiokid on the block!🧫
#MicrobioSky #IDSky #MedSky #AMR #AntimicrobialResistance
#MicrobioSky #IDSky #MedSky #AMR #AntimicrobialResistance
New research article
Data-driven diagnostic reform in Ethiopia's transition to pLDH-based #malaria rapid diagnostic tests amid rising pfhrp2/3 deletions: a multisite, facility-based, cross-sectional study
www.thelancet.com/journals/lan...
#IDSky #ClinMicro #MicroSky #OpenAccess #OA
Data-driven diagnostic reform in Ethiopia's transition to pLDH-based #malaria rapid diagnostic tests amid rising pfhrp2/3 deletions: a multisite, facility-based, cross-sectional study
www.thelancet.com/journals/lan...
#IDSky #ClinMicro #MicroSky #OpenAccess #OA
September 29, 2026 at 11:59 AM
New research article
Data-driven diagnostic reform in Ethiopia's transition to pLDH-based #malaria rapid diagnostic tests amid rising pfhrp2/3 deletions: a multisite, facility-based, cross-sectional study
www.thelancet.com/journals/lan...
#IDSky #ClinMicro #MicroSky #OpenAccess #OA
Data-driven diagnostic reform in Ethiopia's transition to pLDH-based #malaria rapid diagnostic tests amid rising pfhrp2/3 deletions: a multisite, facility-based, cross-sectional study
www.thelancet.com/journals/lan...
#IDSky #ClinMicro #MicroSky #OpenAccess #OA
Every person affected by leprosy & lymphatic filariasis has a story that deserves to be heard. A story of resilience, a story of hope. We are proud to always focus on the person and not just the disease, which is why we want to tell their stories.
www.lepra.org.uk/real-life-stories
#IDSKy #MEDSky
www.lepra.org.uk/real-life-stories
#IDSKy #MEDSky
September 29, 2026 at 10:00 AM
Every person affected by leprosy & lymphatic filariasis has a story that deserves to be heard. A story of resilience, a story of hope. We are proud to always focus on the person and not just the disease, which is why we want to tell their stories.
www.lepra.org.uk/real-life-stories
#IDSKy #MEDSky
www.lepra.org.uk/real-life-stories
#IDSKy #MEDSky
We're in Ann Arbor for the #SCACM Fall Meeting!
Stop by and meet the Q-linea team to learn more about ASTar and how rapid antimicrobial susceptibility testing can support timely treatment decisions and patient care.
Looking forward to a great day of learning and discussion.
#IDSky #RapidAST
Stop by and meet the Q-linea team to learn more about ASTar and how rapid antimicrobial susceptibility testing can support timely treatment decisions and patient care.
Looking forward to a great day of learning and discussion.
#IDSky #RapidAST
September 29, 2026 at 9:52 AM
🧠 Clinical case
A 25-year-old man with HIV on ART (CD4: 218/mm³) presents with headache and diplopia.
Examination shows an isolated right VI nerve palsy.
He also has low-back pain and constipation.
👁️ What is your differential diagnosis?
#MedEd #IDSky #neurology #clinicalcase
A 25-year-old man with HIV on ART (CD4: 218/mm³) presents with headache and diplopia.
Examination shows an isolated right VI nerve palsy.
He also has low-back pain and constipation.
👁️ What is your differential diagnosis?
#MedEd #IDSky #neurology #clinicalcase
September 29, 2026 at 9:46 AM
🧠 Clinical case
A 25-year-old man with HIV on ART (CD4: 218/mm³) presents with headache and diplopia.
Examination shows an isolated right VI nerve palsy.
He also has low-back pain and constipation.
👁️ What is your differential diagnosis?
#MedEd #IDSky #neurology #clinicalcase
A 25-year-old man with HIV on ART (CD4: 218/mm³) presents with headache and diplopia.
Examination shows an isolated right VI nerve palsy.
He also has low-back pain and constipation.
👁️ What is your differential diagnosis?
#MedEd #IDSky #neurology #clinicalcase
Look beyond the headlines. What do the latest WHO leprosy figures mean? Maria del Mar Marais, Head of Programme Management Lepra UK, breaks down what the 2025 data really tells us at the midpoint of the WHO Global Leprosy Strategy 2021–2030: https://ow.ly/T1Jr50ZS7Ri
#IDSky #GlobalHealth #MedSky
#IDSky #GlobalHealth #MedSky
Beyond the headline: What the 2025 global leprosy data tells us
The 2025 World Health Organization (WHO) update gives a mixed picture at the midpoint of the Global Leprosy Strategy 2021–2030.
ow.ly
September 29, 2026 at 8:00 AM
Look beyond the headlines. What do the latest WHO leprosy figures mean? Maria del Mar Marais, Head of Programme Management Lepra UK, breaks down what the 2025 data really tells us at the midpoint of the WHO Global Leprosy Strategy 2021–2030: https://ow.ly/T1Jr50ZS7Ri
#IDSky #GlobalHealth #MedSky
#IDSky #GlobalHealth #MedSky
#Medsky🧪 #IDsky #microsky #publichealth In this study, increasing doses of antimicrobial prophylaxis did not improve SSI (surgical site infection )prevention.
@eclinicalmed.bsky.social
www.thelancet.com/journals/ecl...
@eclinicalmed.bsky.social
www.thelancet.com/journals/ecl...
Safety of routine antimicrobial prophylaxis for surgery (SAPPHIRE): a prospective multi-centre cohort study
In this study, increasing doses of antimicrobial prophylaxis did not improve SSI prevention.
Antimicrobial side effect rates were much higher than expected, especially among patients
receiving more do...
www.thelancet.com
September 29, 2026 at 6:43 AM
#Medsky🧪 #IDsky #microsky #publichealth In this study, increasing doses of antimicrobial prophylaxis did not improve SSI (surgical site infection )prevention.
@eclinicalmed.bsky.social
www.thelancet.com/journals/ecl...
@eclinicalmed.bsky.social
www.thelancet.com/journals/ecl...
#Medsky🧪 #IDSky #publichealth Understanding of #longCOVID has evolved dramatically since it was first described in the early days of the pandemic. #LongCOVID was initially dismissed by much of the medical community altogether…
@weselymd.bsky.social
@weselymd.bsky.social
September 29, 2026 at 6:30 AM
#Medsky🧪 #IDSky #publichealth Understanding of #longCOVID has evolved dramatically since it was first described in the early days of the pandemic. #LongCOVID was initially dismissed by much of the medical community altogether…
@weselymd.bsky.social
@weselymd.bsky.social
"Our findings underscore that infectious disease spillover and emergence are multi-causal, and that no one-size-fits-all strategy can prevent #epidemics and #pandemics."
So what can we do, then?
See suggestions in this interesting (but sobering) read
#IDSky
So what can we do, then?
See suggestions in this interesting (but sobering) read
#IDSky
If you missed it last week, we published the largest ever study on emerging infectious diseases. Not really in vogue right now, but the next pandemic will come sooner than you think. Key lessons: nature-based solutions where you can, health system strengthening always. www.nature.com/articles/s41...
September 29, 2026 at 6:19 AM
"Our findings underscore that infectious disease spillover and emergence are multi-causal, and that no one-size-fits-all strategy can prevent #epidemics and #pandemics."
So what can we do, then?
See suggestions in this interesting (but sobering) read
#IDSky
So what can we do, then?
See suggestions in this interesting (but sobering) read
#IDSky
#Medsky🧪 #pedsky #IDsky #vaccinesmatter #obsky #neurosky #publichealth Are #congenitalTORCH ( #toxoplasmosis, #syphilis, #rubella, #cytomegalovirus, or #herpessimplex) infections associated with neurodevelopmental and psychiatric outcomes?
September 29, 2026 at 6:15 AM
#Medsky🧪 #pedsky #IDsky #vaccinesmatter #obsky #neurosky #publichealth Are #congenitalTORCH ( #toxoplasmosis, #syphilis, #rubella, #cytomegalovirus, or #herpessimplex) infections associated with neurodevelopmental and psychiatric outcomes?
Really enjoyed writing this with Ahmad Mourad & @cortes-penfield.bsky.social! See our take on the SNAP trial's results.
Well-designed trials supported by other RCTs and observational data warrant elevation of cefazolin to the top spot in MSSA bacteremia treatment #IDSky
Well-designed trials supported by other RCTs and observational data warrant elevation of cefazolin to the top spot in MSSA bacteremia treatment #IDSky
📢 Our latest commentary, "Old Drugs, New Evidence: SNAP and the Randomized Case for Cefazolin in MSSA Bacteremia," is now available. Explore the evolving evidence and its implications for clinical practice.
@gurujosh.bsky.social @steventong.bsky.social
clarityinitiative.org/commentaries...
@gurujosh.bsky.social @steventong.bsky.social
clarityinitiative.org/commentaries...
September 29, 2026 at 4:30 AM
Really enjoyed writing this with Ahmad Mourad & @cortes-penfield.bsky.social! See our take on the SNAP trial's results.
Well-designed trials supported by other RCTs and observational data warrant elevation of cefazolin to the top spot in MSSA bacteremia treatment #IDSky
Well-designed trials supported by other RCTs and observational data warrant elevation of cefazolin to the top spot in MSSA bacteremia treatment #IDSky
In 🇦🇺, the treatment of meloidosis is 2-8 weeks of IV mero/ceftaz followed by 3-6 months of high dose PO Trim/Sulfa
In single center RCT, comparing IV to IV+PO:
-Less relapse in IV+PO (29% vs. 6%)
-81%in PO hd ADR in Trim/Sulfa group requiring 5admissions (1 ICU)‼️
doi.org/10.1093/ofid...
#IDSky
In single center RCT, comparing IV to IV+PO:
-Less relapse in IV+PO (29% vs. 6%)
-81%in PO hd ADR in Trim/Sulfa group requiring 5admissions (1 ICU)‼️
doi.org/10.1093/ofid...
#IDSky
Omitting the eradication phase of treatment of adults with melioidosis: a pilot, single-center, randomized control trial
Prolonged intravenous antibiotics alone will cure many patients with melioidosis, however some still require oral eradication therapy. The potential for re
doi.org
September 28, 2026 at 10:17 PM
In 🇦🇺, the treatment of meloidosis is 2-8 weeks of IV mero/ceftaz followed by 3-6 months of high dose PO Trim/Sulfa
In single center RCT, comparing IV to IV+PO:
-Less relapse in IV+PO (29% vs. 6%)
-81%in PO hd ADR in Trim/Sulfa group requiring 5admissions (1 ICU)‼️
doi.org/10.1093/ofid...
#IDSky
In single center RCT, comparing IV to IV+PO:
-Less relapse in IV+PO (29% vs. 6%)
-81%in PO hd ADR in Trim/Sulfa group requiring 5admissions (1 ICU)‼️
doi.org/10.1093/ofid...
#IDSky
Fur farming is appalling d/t ethical concerns. It should also be considered high-risk, like bushmeat and live animal markets, which are directly associated with past and future pandemics. Why so little US biosecurity and active surveillance?
#EpiSky #IDSky #MedSky #OneHealth #PublicHealth #Anthrozoo
#EpiSky #IDSky #MedSky #OneHealth #PublicHealth #Anthrozoo
Mink farming poses risks for future viral pandemics | PNAS
Mink farming poses risks for future viral pandemics
doi.org
September 28, 2026 at 9:56 PM
Fur farming is appalling d/t ethical concerns. It should also be considered high-risk, like bushmeat and live animal markets, which are directly associated with past and future pandemics. Why so little US biosecurity and active surveillance?
#EpiSky #IDSky #MedSky #OneHealth #PublicHealth #Anthrozoo
#EpiSky #IDSky #MedSky #OneHealth #PublicHealth #Anthrozoo
IDSA and ESCMID released consensus statements to assist in managing individuals with Staphylococcus aureus and follow-up blood cultures. This review will focus on adult patients and additional information on the pediatric population.
#IDsky #Medsky
www.contagionlive.com/view/idsa-es...
#IDsky #Medsky
www.contagionlive.com/view/idsa-es...
IDSA/ESCMID Statement on Staphylococcus aureus: Follow-Up Blood Cultures | Contagion Live
Staphylococcus aureus Bacteremia (SAB) causes significant morbidity and globally is the leading cause of death from bloodstream infection. This month, the IDSA and ESCMID released 7 consensus statemen...
www.contagionlive.com
September 28, 2026 at 8:54 PM
IDSA and ESCMID released consensus statements to assist in managing individuals with Staphylococcus aureus and follow-up blood cultures. This review will focus on adult patients and additional information on the pediatric population.
#IDsky #Medsky
www.contagionlive.com/view/idsa-es...
#IDsky #Medsky
www.contagionlive.com/view/idsa-es...
Viral remnants causing vascular damage. Long COVID claims surging 2-3 weeks post-ER. AI chatbots duped by political "pink slime."
This week's newsletter was so packed I had to split it into 2 parts!
Part I (COVID): buff.ly/nSoGZsi
Part II (Med News): buff.ly/MEx3iKr
#medsky #IDsky
This week's newsletter was so packed I had to split it into 2 parts!
Part I (COVID): buff.ly/nSoGZsi
Part II (Med News): buff.ly/MEx3iKr
#medsky #IDsky
September 28, 2026 at 6:04 PM
Viral remnants causing vascular damage. Long COVID claims surging 2-3 weeks post-ER. AI chatbots duped by political "pink slime."
This week's newsletter was so packed I had to split it into 2 parts!
Part I (COVID): buff.ly/nSoGZsi
Part II (Med News): buff.ly/MEx3iKr
#medsky #IDsky
This week's newsletter was so packed I had to split it into 2 parts!
Part I (COVID): buff.ly/nSoGZsi
Part II (Med News): buff.ly/MEx3iKr
#medsky #IDsky
Routine #MeningococcalBVaccine rates remain low across the United States, highlighting the need for improved delivery, particularly among high-risk populations. #IDSky
Meningococcal B Vaccine Coverage Remains Suboptimal Across the US
From 2015 to 2023, US MenB rates remained low, marked by significant regional and demographic disparities.
www.infectiousdiseaseadvisor.com
September 28, 2026 at 5:24 PM
Routine #MeningococcalBVaccine rates remain low across the United States, highlighting the need for improved delivery, particularly among high-risk populations. #IDSky
Confirmed measles cases in USA reach 3659, with ongoing outbreaks in Pennsylvania, Wisconsin, and Illinois via @bhadeliamd.bsky.social and her team at Boston U
#publichealth #EpiSky #vaccines #IDSky
#publichealth #EpiSky #vaccines #IDSky
BEACON
Track biological threats, share vital information, and collaborate on solutions for community protection and preparedness.
beaconbio.org
September 28, 2026 at 4:14 PM
Confirmed measles cases in USA reach 3659, with ongoing outbreaks in Pennsylvania, Wisconsin, and Illinois via @bhadeliamd.bsky.social and her team at Boston U
#publichealth #EpiSky #vaccines #IDSky
#publichealth #EpiSky #vaccines #IDSky
Surveillance data for invasive meningococcal disease in the USA has revealed shifting serogroup dominance, outbreaks beyond traditional settings, and increasing incidence among adults.
How should the prevention framework adapt to keep up with these changes?
👉️ buff.ly/XdNVWBi
#IDSky
How should the prevention framework adapt to keep up with these changes?
👉️ buff.ly/XdNVWBi
#IDSky
Burden of Invasive Meningococcal Disease: Evolving Epidemiology and Implications for Prevention Policy
Surveillance data for invasive meningococcal disease (IMD) in the USA has revealed shifting serogroup dominance, outbreaks extending beyond traditional settings, and increasing incidence among…
www.springermedicine.com
September 28, 2026 at 3:15 PM
Surveillance data for invasive meningococcal disease in the USA has revealed shifting serogroup dominance, outbreaks beyond traditional settings, and increasing incidence among adults.
How should the prevention framework adapt to keep up with these changes?
👉️ buff.ly/XdNVWBi
#IDSky
How should the prevention framework adapt to keep up with these changes?
👉️ buff.ly/XdNVWBi
#IDSky
🆕 Just published in Leprosy Review Vol 97/3
Practical knowledge of nursing for leprosy sanatorium residents based on their historical background by Mari Ito
https://leprosyreview.org/article/97/3/20-26029
#Leprosy #Nursing #IDSky #MedSky
Practical knowledge of nursing for leprosy sanatorium residents based on their historical background by Mari Ito
https://leprosyreview.org/article/97/3/20-26029
#Leprosy #Nursing #IDSky #MedSky
September 28, 2026 at 12:00 PM
🆕 Just published in Leprosy Review Vol 97/3
Practical knowledge of nursing for leprosy sanatorium residents based on their historical background by Mari Ito
https://leprosyreview.org/article/97/3/20-26029
#Leprosy #Nursing #IDSky #MedSky
Practical knowledge of nursing for leprosy sanatorium residents based on their historical background by Mari Ito
https://leprosyreview.org/article/97/3/20-26029
#Leprosy #Nursing #IDSky #MedSky
The evaluation covers:
▪️ HIV/AIDS Surveillance in Europe 2025 – 2024 data (bit.ly/4henpf4)
▪️ Tuberculosis surveillance and monitoring in Europe 2024 – 2022 data (bit.ly/4hC7XbI)
#TB #HIV #AIDS #ECDC #IDsky #EpiSky
▪️ HIV/AIDS Surveillance in Europe 2025 – 2024 data (bit.ly/4henpf4)
▪️ Tuberculosis surveillance and monitoring in Europe 2024 – 2022 data (bit.ly/4hC7XbI)
#TB #HIV #AIDS #ECDC #IDsky #EpiSky
HIV/AIDS Surveillance in Europe 2025 – 2024 data
This report presents HIV/AIDS surveillance data for 2024, which shows significant variation in epidemic patterns and trends across the WHO European Region.
bit.ly
September 28, 2026 at 11:23 AM
The evaluation covers:
▪️ HIV/AIDS Surveillance in Europe 2025 – 2024 data (bit.ly/4henpf4)
▪️ Tuberculosis surveillance and monitoring in Europe 2024 – 2022 data (bit.ly/4hC7XbI)
#TB #HIV #AIDS #ECDC #IDsky #EpiSky
▪️ HIV/AIDS Surveillance in Europe 2025 – 2024 data (bit.ly/4henpf4)
▪️ Tuberculosis surveillance and monitoring in Europe 2024 – 2022 data (bit.ly/4hC7XbI)
#TB #HIV #AIDS #ECDC #IDsky #EpiSky
📢 EU-WISH partners are meeting in Vienna!
🗓️ 6-8 October 2026, we will gather at @ages.at in Vienna for the 2nd EU-WISH International Workshop and Consortium Meeting.
We come together to:
• reflect on achievements;
• review ongoing activities;
• identify our next steps
#EU_WISH #IDsky #Episky
🗓️ 6-8 October 2026, we will gather at @ages.at in Vienna for the 2nd EU-WISH International Workshop and Consortium Meeting.
We come together to:
• reflect on achievements;
• review ongoing activities;
• identify our next steps
#EU_WISH #IDsky #Episky
September 28, 2026 at 10:40 AM